GCP
PEAR

GSA Capital Partners’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

GSA Capital Partners’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-28,900
Closed -$146K – 1938
2022
Q1 		$146K Buy
+28,900
New +$146K 0.02% 1237